About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04073836

GMA and Peri in Moderate-late Preterms

To analyze the relationship between the early diagnosis of cerebral palsy with the risk factors of this pathology in moderate and late premature infants

Lead sponsor: University of Castilla-La Mancha•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Javier Merino Andrés, MsC

CONTACT

925268800 Javier.Merino@uclm.es

Sponsors

Lead Sponsor

University of Castilla-La Mancha

Analyze a sample of moderate and late premature infants using general movements and verify which of them would have an early diagnosis of cerebral palsy and relate it to their risk factors for this pathology.

Age

0 - 0 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subjects who were born between the week 32 + 0 days and the week 36 + 6 days and who are admitted to the Hospital Nuestra Señora del Prado de Talavera de la Reina or the Hospital Virgen de la Salud de Toledo.

Exclusion Criteria

•Any type of pre and perinatal diagnostic neurological involvement.
•Any type of pathology associated with prematurity.
•Children who have prescribed any of the following medications (10):
•* Barbiturates
•* Antiepileptic
•* Indomethacin
•* Dexamethasone

Related studies

RECRUITINGPhase 4

Prolonged Progesterone to Prevent Preterm Birth From IVF - ET

NCT05787509 · Preterm Birth

RECRUITINGPhase 2/3

Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial

NCT07424846 · Preterm Birth, Low Birthweight Neonate, and more

RECRUITINGPhase 4

Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes

NCT07261787 · Neonates and Preterm Infants, Infant Respiratory Distress Syndrome, and more

Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix

NCT07372495 · Preterm

RECRUITINGPhase 2

Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder

NCT05336188 · Opioid-Related Disorders, Mobile Applications, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 29, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment150

Start dateJan 2019

Last updatedAug 29, 2019

Condition

Preterm Assessment Risk Factor Cerebral Palsy

Locations shown

Javier Merino Andrés

Toledo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 29, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions